TCL Archive FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity. September 29, 2000
TCL Archive In Brief: Senate Sets NCI rescission At $14 Million Baltimore Program Conversation To Cancer Center Will Be asked May 15, 1981